A generic version of Hydrea is available
Hydrea is FDA-approved to treat a certain type of chronic myeloid leukemia (CML) in adults
Hydrea is also available as a generic drug
Hydroxyurea, a once daily oral medication
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens
In children with sickle cell anemia (SCA) in sub-Saharan Africa, treatment with hydroxyurea at the maximum tolerated
Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell disease
Currently, that level is $43,740 for an individual and $90,000 for a family of four, with sliding scales for household size